{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:37:24Z","timestamp":1794670644918,"version":"4.9.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ijpharm.2011.08.018","type":"journal-article","created":{"date-parts":[[2011,8,18]],"date-time":"2011-08-18T04:01:19Z","timestamp":1313640079000},"page":"133-140","source":"Crossref","is-referenced-by-count":132,"title":["Production and characterization of antioxidant apigenin nanocrystals as a novel UV skin protective formulation"],"prefix":"10.1016","volume":"420","author":[{"given":"Loaye","family":"Al Shaal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjita","family":"Shegokar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer H.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2011.08.018_bib0005","first-page":"877","article-title":"smartCrystal combination technology\u2014scale up from lab to pilot scale and long term stability","volume":"65","author":"Al Shaal","year":"2010","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1039\/b009171p","article-title":"Methods for testing antioxidant activity","volume":"127","author":"Antolovich","year":"2002","journal-title":"Analyst"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0015","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1088\/0957-4484\/16\/12\/014","article-title":"Design of biodegradable nanoparticles: a novel approach to encapsulating poorly soluble phytochemical ellagic acid","volume":"16","author":"Bala","year":"2005","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0023-6438(95)80008-5","article-title":"Use of a free-radical method to evaluate antioxidant activity","volume":"28","author":"Brandwilliams","year":"1995","journal-title":"Food Sci. Technol.\u2014LWT"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0025","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/0378-5173(92)90184-4","article-title":"The relationship between particle size and solubility","volume":"82","author":"Buckton","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0030","first-page":"726","article-title":"Development of topical nanoemulsions containing quercetin and 3-O-methylquercetin","volume":"64","author":"Fasolo","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0035","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1515\/znc-1997-11-1215","article-title":"Antioxidant activity of flavones from Scutellaria baicalensis in lecithin liposomes","volume":"52","author":"Gabrielska","year":"1997","journal-title":"Z. Naturforsch. C\u2014J. Biosci."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0040","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1211\/0022357044382","article-title":"Encapsulation of naturally occurring flavonoids into liposomes: physicochemical properties and biological activity against human cancer cell lines","volume":"56","author":"Goniotaki","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0891-5849(92)90184-I","article-title":"Antioxidant potential of ferulic acid","volume":"13","author":"Graf","year":"1992","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1196\/annals.1354.003","article-title":"Free radical theory of aging: an update: increasing the functional life span","volume":"1067","author":"Harman","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0163-7258(02)00298-X","article-title":"The biochemistry and medical significance of the flavonoids","volume":"96","author":"Havsteen","year":"2002","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2005.05.014","article-title":"Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine","volume":"299","author":"Hecq","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.copbio.2008.03.003","article-title":"Nutrients and phytochemicals: from bioavailability to bioefficacy beyond antioxidants","volume":"19","author":"Holst","year":"2008","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jconrel.2005.11.013","article-title":"Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs","volume":"111","author":"Jinno","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0075","series-title":"Particle Design for APIs and Drug Products","article-title":"NanoCrystal\u00ae Technology: a formulation approach for poorly water soluble compounds","author":"Keck","year":"2008"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0080","first-page":"124","article-title":"Second generation of drug nanocrystals for delivery of poorly soluble drugs: smartCrystals technology","volume":"2","author":"Keck","year":"2008","journal-title":"Dosis"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0085","article-title":"Influence of different stabilizers on particle size of apigenin nanosuspensions produced by high pressure homogenization","volume":"vol. 36","author":"Ker\u010d","year":"2009"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0090","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ultramic.2008.04.047","article-title":"Effect of reaction temperatures and media on crystal structure of colloidal nanocrystals synthesized from an aerosol flow system","volume":"108","author":"Kim","year":"2008","journal-title":"Ultramicroscopy"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0095","series-title":"United States Patent 6,607,784","article-title":"Microprecipitation method for preparing submicron suspensions","author":"Kipp","year":"2003"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0105","series-title":"AAPS Annual Meeting","article-title":"Preparation and physical evaluation of ascorbyl palmitate nanosuspensions","author":"Kobierski","year":"2008"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0110","series-title":"European Workshop on Particulate Systems","article-title":"Production of Hesperidin dermal nanocrystals by novel smartCrystal combination technology","author":"Kobierski","year":"2008"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0115","first-page":"741","article-title":"Resveratrol nanosuspensions for dermal application\u2014production, characterization, and physical stability","volume":"64","author":"Kobierski","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0120","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1080\/01926230290166724","article-title":"Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification","volume":"30","author":"Kohen","year":"2002","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0125","series-title":"IIR Drug Delivery Partnerships\u2122 Meeting","article-title":"Workshop Nanotechnology\u2014solid particles, lipids and nanocomplexes","author":"Liversidge","year":"2003"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jdermsci.2010.03.003","article-title":"Role of antioxidants in the skin: anti-aging effects","volume":"58","author":"Masaki","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijpharm.2008.11.029","article-title":"Development of an oral rutin nanocrystal formulation","volume":"370","author":"Mauludin","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0140","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijpharm.2008.12.030","article-title":"Production and characterization of Hesperetin nanosuspensions for dermal delivery","volume":"371","author":"Mishra","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1467-2494.1995.tb00113.x","article-title":"Protective effect evaluation of free radical scavengers on UVB induced human cutaneous erythema by skin reflectance spectrophotometry","volume":"17","author":"Montenegro","year":"1995","journal-title":"Int. J. Cosmetic Sci."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0150","series-title":"PCT\/EP2006\/003377","article-title":"Method for carefully producing ultrafine particle suspensions and ultrafine particles and use thereof","author":"M\u00f6schwitzer","year":"2007"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0155","series-title":"AAPS Annual Meeting","article-title":"Rutin drug nanocrystals for dermal cosmetic application","author":"M\u00fcller","year":"2007"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0160","first-page":"948","article-title":"Emulsions for Intravenous Application. II. Destabilisation and stabilisation mechanisms in fat emulsions","volume":"55","author":"M\u00fcller","year":"1993","journal-title":"Die Pharm. Ind."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0165","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0378-5173(02)00040-6","article-title":"Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability","volume":"237","author":"M\u00fcller","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0170","series-title":"Pharmaceutical Emulsions and Suspensions","first-page":"383","article-title":"Nanosuspensions for the formulation of poorly soluble drugs","author":"M\u00fcller","year":"2000"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0175","series-title":"Annual Meeting of the American Association of Pharmaceutical Scientists (AAPS)","article-title":"Rutin smartCrystals: bioactivity enhancement and stability against electrolytes","author":"M\u00fcller","year":"2008"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0180","series-title":"PCT\/EP2006\/009930","article-title":"Method and device for producing very fine particles and coating such particles","author":"M\u00fcller","year":"2007"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0185","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10517-010-0876-5","article-title":"Effects of a nanocomplex containing antioxidant lipid, and amino acid on thermal burn wound surface","volume":"149","author":"Naumov","year":"2010","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0190","first-page":"144","article-title":"Resveratrol in cancer management: where are we and where we go from here?","volume":"1215","author":"Ndiaye","year":"2011","journal-title":"Resveratrol Health"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0195","series-title":"Medpharm Scientific","first-page":"143","article-title":"Dissolution properties of soluble drugs: theoretical background and possibilities to improve the dissolution behavior","author":"Nystr\u00f6m","year":"1998"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0200","first-page":"363","article-title":"An overview of phytosomes as an advanced herbal drug delivery system","volume":"4","author":"Patela","year":"2009","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0205","unstructured":"Petersen, R., 2006a. Nanocrystals for use in topical cosmetic formulations and method of production thereof. US Patent 60\/8866233."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0210","series-title":"PCT\/EP2007\/009943","article-title":"Nanocrystals for use in topical formulations and method of production thereof","author":"Petersen","year":"2006"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0215","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.biopha.2007.05.010","article-title":"Interplay among oxidants, antioxidants, and cytokines in skin disorders: present status and future considerations","volume":"61","author":"Portugal","year":"2007","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0220","series-title":"Control of colloid stability through zeta potential; with a closing chapter on its relationship to cardiovascular disease","author":"Riddick","year":"1968"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0225","first-page":"43","article-title":"Oxidative reactions in and on the skin: mechanism and prevention","volume":"108","author":"Rieger","year":"1993","journal-title":"Cosmetic Toiletries"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0230","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1568-1637(02)00024-7","article-title":"UV-light-induced signal cascades and skin aging","volume":"1","author":"Rittie","year":"2002","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0235","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0891-5849(89)90045-2","article-title":"Free radicals in the human epidermis","volume":"6","author":"Schabeuter","year":"1989","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0240","series-title":"Food Phenolics: Sources, Chemistry, Effects, Applications","first-page":"1","article-title":"Food phenolics: an overview","author":"Shahidi","year":"1995"},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0245","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijpharm.2010.07.044","article-title":"Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives","volume":"399","author":"Shegokar","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0250","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1007\/s00018-007-7237-1","article-title":"Polyphenolic phytochemicals\u2014just antioxidants or much more?","volume":"64","author":"Stevenson","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0255","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2710.2001.00338.x","article-title":"Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics","volume":"26","author":"Willems","year":"2001","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ijpharm.2011.08.018_bib0260","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0378-5173(02)00219-3","article-title":"The development of an improved carrier system for sunscreen formulations based on crystalline lipid nanoparticles","volume":"242","author":"Wissing","year":"2002","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311007800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311007800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T04:43:15Z","timestamp":1560487395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517311007800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0378517311007800"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2011.08.018","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}